• Advances in the Understanding of Etiology (I)
• 30 min
  1. Infection and autoimmunity: a two-way relationship

  • Dr. Ricard Cervera
• 35 min
  2. Autoimmunity and atherosclerosis

  • Prof. Johan Frostegard
• 47 min
  3. Endothelium and autoimmunity

  • Prof. Pier Luigi Meroni
• Advances in the Understanding of Etiology (II)
• 22 min
  4. Prolactin has a pathogenic role in systemic lupus erythematosus

  • Prof. Luis Jara-Quezada
• 44 min
  5. Sjögren's syndrome: current knowledge and future prospects

  • Prof. Athanasios G. Tzioufas
• 51 min
  6. Genetic and environmental triggers of autoimmune thyroid diseases

  • Prof. Yaron Tomer
• Advances in Pathogenesis and Clinical Manifestation
• 38 min
  7. The catastrophic antiphospholipid syndrome and the microangiopathic antiphospholipid syndrome

  • Prof. Ronald Asherson
• 20 min
  8. Pathogenic mechanisms of autoantibodies: circulating and local antibodies that form immune complexes

  • Dr. Luís Eduardo Coelho Andrade
• 34 min
  9. Pathogenic mechanisms of autoantibodies: antibodies to intracellular and membrane-bound antigens

  • Dr. Luís Eduardo Coelho Andrade
• 43 min
  10. What causes primary biliary cholangitis?

  • Dr. M. Eric Gershwin
• 30 min
  11. Capillaroscopy in autoimmune rheumatic diseases

  • Prof. Maurizio Cutolo
• Advances in Diagnostic Methodologies (I)
• 26 min
  12. The past, present & future of ANA testing: history and challenges of ANA

  • Prof. Marvin J. Fritzler
• 33 min
  13. The past, present & future of ANA testing: changing bandwidth and future of ANA

  • Prof. Marvin J. Fritzler
• 36 min
  14. Diagnostic methods in autoimmunity

  • Mr. Steven Binder
• 24 min
  15. Systemic lupus erythematosus: novel aspects of pathogenesis and treatment 1

  • Prof. Chaim Putterman
  • Dr. Noa Schwartz
• 28 min
  16. Systemic lupus erythematosus: novel aspects of pathogenesis and treatment 2

  • Prof. Chaim Putterman
  • Dr. Noa Schwartz
• 48 min
  17. Novel aspects of systemic sclerosis

  • Prof. Gabriele Valentini
• Advances in Diagnostic Methodologies (II)
• 46 min
  18. An update on the multiple faces of celiac disease

  • Prof. Aaron Lerner
• 23 min
  19. Protective autoantibodies

  • Prof. Elias Toubi
• 32 min
  20. CD44 genetic deletion enhances and CD44 antibody targeting attenuates autoimmune inflammation

  • Prof. David Naor
• 44 min
  21. Rheumatic fever: a model of a post-infectious autoimmune disease

  • Prof. Jorge Kalil
• Treatments of autoimmune diseases
• 38 min
  22. Intravenous immunoglobulins: clinical evidence

  • Prof. Shaye Kivity
• Latest Developments in the Field
• 26 min
  23. Adjuvants and autoimmunity

  • Dr. Eitan Israeli
• 46 min
  24. Antiphospholipid syndrome (APS): from pathogenesis to treatment

  • Prof. Roger Levy
• 24 min
  25. Vitamin D and autoimmunity

  • Dr. Shir Azrielant
• 28 min
  26. Pregnancy in rheumatic diseases

  • Prof. Pier Luigi Meroni
• Archived Lectures *These may not cover the latest advances in the field
• 47 min
  27. Pathogenic mechanisms of autoantibodies

  • Prof. Cees Kallenberg
• 41 min
  28. B lymphocytes on the frontline of autoimmunity

  • Prof. Pierre Youinou
• 42 min
  29. Apoptotic cell clearance deficiency

  • Prof. Martin Herrmann
• 34 min
  30. Auto-antibodies as predictors of autoimmune disease

  • Dr. Nicola Bizzaro
• 46 min
  31. Innate immunity and natural autoantibodies

  • Prof. Luc Mouthon
• 45 min
  32. Accelerated atherosclerosis in autoimmune rheumatic disease

  • Dr. Andrea Doria
• 47 min
  33. Pregnancy in autoimmune rheumatic diseases

  • Prof. Angela Tincani
• 42 min
  34. Pulmonary hypertension in the connective tissue disease pathogenesis, clinical features and therapeutic options in 2006

  • Prof. Ronald Asherson
• 39 min
  35. Use of algorithms for high quality diagnostics and handling of patients with autoimmune rheumatic diseases

  • Dr. Allan Wiik
• 24 min
  36. Immunologic mechanisms in systemic lupus erythematosus

  • Prof. Kok-Yong Fong
• 23 min
  37. Osteoimmunology

  • Prof. João Eurico Fonseca
  • Ms. Joana Caetano-Lopes
• 43 min
  38. ANCA-associated systemic vasculitides

  • Prof. Loic Guillevin
• 23 min
  39. The common origin for diverse autoimmune diseases

  • Prof. Juan-Manuel Anaya
• 76 min
  40. Anti-cytokine therapy in rheumatoid arthritis

  • Prof. Piercarlo Sarzi-Puttini
• 40 min
  41. Sjogren's syndrome: autoimmune epithelitis

  • Prof. Haralampos Moutsopoulos
• 31 min
  42. Vitamin D and autoimmunity

  • Dr. Howard Amital
• 25 min
  43. Intravenous immunoglobulins: myth and reality

  • Prof. Zera Tellier

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Autoimmunity
3. Etiology of autoimmune disease
4. Induction of autoimmunity: mechanisms
5. The spectrum of autoimmune diseases
6. Organ-specific and non-organ-specific disorders
7. Overlap of autoantibodies
8. Stimulating anti-thyroid antibodies
9. Placental transfer of stimulating anti-thyroid Abs
10. The spectrum of autoimmune diseases (selection)
11. Pathogenetic immune responses
12. Role of auto-Abs in autoimmune diseases
13. Anti-GBM, Goodpasture's syndrome (1)
14. Anti-GBM, Goodpasture's syndrome (2)
15. Anti-GBM disease membranes
16. Type 2 reaction
17. Anti-GBM, Goodpasture's syndrome (3)
18. Type 3 reaction: formation of immune complexes
19. SLE-ACR criteria
20. Example of rash
21. Class IV-S (A)
22. Rise in anti-dsDNA and relapse
23. Auto-Abs in lupus nephritis
24. GBM-nucleosome-antibody interaction
25. Auto-Abs to C1q: clinical associations
26. Auto-Abs to C1q: relation to disease activity (1)
27. Auto-Abs to C1q: relation to disease activity (2)
28. Pathogenicity of anti-C1q in lupus nephritis (1)
29. Pathogenicity of anti-C1q in lupus nephritis (2)
30. ANCA-associated vasculitides
31. Anti-neutrophil cytoplasmic Abs (ANCA)
32. c-ANCA, anti-Pr3 and anti-MPO
33. Pathogenetic pathways in the primary vasculitides
34. ANCA-associated vasculitis: pauci-immune
35. Clinical evidence for pathogenicity of ANCA (1)
36. Clinical evidence for pathogenicity of ANCA (2)
37. ANCA-induced PMN activation
38. MPO-ANCA are pathogenic in vivo (1)
39. MPO-ANCA are pathogenic in vivo (2)
40. Are PR3-ANCA pathogenic in vivo?
41. Nasal carriage of S. aureus and relapses of WG
42. Are ANCA pathogenic?
43. Pathogenic mechanisms of auto-Abs?

Topics Covered

• Loss of tolerance for "self"
• Immune response to "self"
• Self destruction
• Etiology of autoimmune diseases: endogenous and exogenous factors
• Mechanisms of autoimmunity
• The spectrum of autoimmune diseases
• Organ-specific and non-organ-specific disorders
• Overlap of autoantibodies
• Anti-thyroid antibodies
• Pathogenic immune responses
• Systemic autoimmune diseases
• Anti-GMB and Goodpasture's syndrome
• Anti-C1q
• ANCA-associated vasculitis

Links

Series:

• Autoimmunity

Categories:

• Clinical Practice
• Immunology

Therapeutic Areas:

• Immunology & Inflammation

Talk Citation

Publication History

• Published on October 1, 2007
• Archived on June 30, 2020

Financial Disclosures

• Prof. Cees Kallenberg has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.